E BOLA Virus (EBOV) infection affects humans beings in the last four decades with the deadliest outbreak at 2015 in West Africa, leaving more than 10,000 deaths. The virus harms the liver of the patient when direct contact with contaminated body fluids or blood is occurred. L polymerase is one of the viral proteins responsible for the viral RNA replication. Inhibition of the viral polymerase succeeded is in stopping the infection of other viruses such as Hepatitis C Virus (HCV). National Center for Biotechnology Information (NCBI) protein database has 2123 sequences for L polymerase. In present research, the sequence and phylogenetic analysis are utilized to understand the non-redundant sequence coming from different countries. Based on the sequence similarity, the solved structure of vesicular stomatitis virus (PDB ID: 5A22) is used in this work to suggest the active site of the EBOV RdRp domain. Two newly released sequences (APT69557.1 and ALX33626.1 for the Sudan and Zaire, respectively) are based on the phylogenetic analysis, show interestingly a divert, mutation and distance from its subgroups suggesting a new emerged isoform of EBOV RdRp. The active site motif, GDN, would be targeted by polymerase inhibitors succeeded in other viruses to get stop the infection.
Introduction
Ebola virus is stand out amongst the most harmful pathogens known to contaminate people. 1 The first recognized Ebola outbreak occurred at 1976, near Ebola River in Zaire (now Democratic Republic of Congo, DRC). In recent years, more than 20 flare-ups have happened in Africa, with the vast majority of the known episodes happenned in the previous 20 years. 2 The main routes of Ebola virus transmission are direct contact with asymptomatic Ebola patient's blood and body fluids (including but not restricted to urine, feces, vomitus, saliva, and sweat) through breaks in the skin or inoculation into the mouth, nose or eyes. Human contamination can likewise happen through contact with wild animals, such as by hunting, butchering or preparing meat from infected animals 3 . Ebolavirus (EBOV) causes an exceptionally infectious zoonotic disease, affects humans and other primates. Although the natural outbreak of the EBOV is yet restricted to Africa, fast methods for individual's correspondence, high viral transmissibility, and high mortality rate have made the EBOV a serious global health threat. Currently, there is no effective direct acting anti-EBOV drug. EBOV patients receive only palliative therapy. 4 Currently, there are no licensed vaccines or treatments available to combat EBOV disease and as such, research aimed at identifying targets for therapeutic intervention is of high priority. However, the classification of EBOV as a biosafety level 4 (BSL-4) pathogen greatly limits studies using a live virus. 5 Nearly every Ebola virus protein has been characterized for therapeutic targeting potential. 6 The EBOV genome is a negative-sense singlestranded RNA and contains a viral envelope, matrix, and nucleocapsid components. It encodes seven structural proteins: nucleoprotein (NP), polymerase cofactor (VP35, VP40, GP), transcription activator (VP30, VP24), and RNAdependent RNA polymerase (L). 7,8 Viral RNAdependent RNA polymerases (RdRp) are essential for replication of RNA viruses and represent important drug targets. 9 CLUSTALΩ 10 is web -based software service for performing fast and accurate multiple sequence alignments (MSAs) of potentially large numbers of protein or DNA/RNA sequences. It is the latest version of the famous and widely used CLUSTAL MSAs . 11,12 .
The aim of present work to determine the active site of RdRp of EBOV to use in docking method with anti-viral drugs. Study the relationship of EBOV L polymerase sequence by pairwise distance and phylogenetic tree.
Materials and Methods

Multiple sequence alignment
Multiple sequence alignment was performed using the web server CLUSTALΩ 10 . The alignment was ordered and represented using Easy Sequencing in PostScript (ESPript 3.0) web server 13,14 . ESPript 3.0 generates figures of aligned sequences with secondary structure information. It can serve as a tool for structure/ function analyses. ESPript reads text outputs from multiple sequence alignment programs such as CLUSTALΩ and MULTALIN, as well as from programs able to identify secondary structure elements from structure files such as DSSP 15 and STRIDE 16 .
EBOV polymerase Sequence analysis
2123 of EBOV L polymerase protein representing all recorded EBOV outbreaks as retrieved from the National Center for Biotechnology Information (NCBI) http:// www.ncbi.nlm.nih.gov/, 17 . EBOV L polymerase Sequence were downloaded from various countries (Sudan, Reston, Bombali, Zaire, Tai Forest and Bundibugyo) and synthetic construct (that Artificial viruses to understand and prevent viral disease).
EBOV polymerase Sequence selected
21 unique sequences for EBOV L polymerase protein were selsected. Eight from Sudan, three from Reston (United States), two from Bombali (Sierra Leone), three from Zaire, two from Tai Forest (Côte d'Ivoire), two from Bundibugyo (Uganda) and one synthetic construct.
Pairwise distance method and (MEGA) software
Pairwise distance method is used to test the distances between the aligned sequences using Molecular Evolutional Genetics Analysis (MEGA) software 18 in table 1.
Phylogenetic tree
Phylogenetic tree of the aligned sequences is also calculated using MEGA software and represented by the Cladogram.
Results and Discussion
Sequence alignment
To obtain the correct alignment of a large set of sequences, with some of them being only distantly related, it is essential to elaborate an optimal scheme for hierarchical alignment and to delimit the portions of the sequences which are optimal for revealing non-random similarity. Sequences of various sets of negative-strand viral RNA of Ebola polymerases have been downloaded from NCBI http://www.ncbi.nlm.nih.gov/, 17 ., The authors used CLUSTALΩ website 10 to perform multiple sequence alignment of the 21 sequences of RdRp of EBOV L polymerase. The total number of downloaded sequences are 2123 according to various countries (Sudan, Reston, Bombali, Zaire, Tai Forest, Bundibugyo) and synthetic construct.
After reducing the sequences for the RdRp domain, the number of non-redundant sequences becomes 21. The alignment is represented by ESPript 3.0 as shown in Fig.1 . The alignment consists of 1082 amino acids and includes distinct blocks of amino acid residues which could be considered conserved motifs. Overall the sequence similarity is high (highlighted in red in Fig.1 ). The highest sequence identity is 99.91%, and the lowest is 80.74%. The secondary structure of the cryo-EM solved L protein of vesicular stomatitis virus (PDB ID: 5A22) is represented in the top of the alignment. This solved structure represents the best homolog for building the 3D model of EBOV RdRp (89 % coverage and sequence Identity 17.4%). The sequence of the solved structure (PDB ID: 5A22) is aligned against EBOV sequences. Based on the multiple sequence alignment, GDN motif (the reported active site of L protein of vesicular stomatitis virus) is conserved in EBOV with the two aspartate residues protruding from the beta-turn structure (between β13 and β14). This is suggested to be the active site for EBOV RdRp.
Pairwise distance analysis
The pairwise distance for the aligned sequences is represented in table 1. Pairwise distance, that is the minimum number of changes necessary to convert one sequence into another, for the sequences from the same country show shorter values, while the distances increase when aligning two sequences from different countries. Interestingly, Sudan EBOV shows the shortest distances compared to other EBOV sequence under the study. This implies the phylogenetic relevance as reported from the phylogenetic tree shown in Fig. 2 . 
Phylogenetic tree
Phylogenetic tree is inferred from the alignment as described in Materials and methods. A consensus tree inferred using the Maximum likelihood statistical method, bootstrap methods (test of phylogeny) with 100 replications, LG model and others with default parameters (Figure 2 
Conclusion
EBOV RdRp active site is conserved among different sequence. The sequences analysis in the present study leads to RdRp inhibitors of other viruses such as HCV can be used to target EBOV L polymerase. Getting the 3D structure of EBOV L polymerase is the next step to test such polymerase inhibitors.
Among the observations of the phylogenetic analysis; sequences are occurred leading to distantly mutated isoforms and this should be as a target for future investigation.
